Literature DB >> 3055956

Clinical features and natural history in adults with IgA nephropathy.

G D'Amico1.   

Abstract

Two different clinical syndromes might be observed at presentation in most patients with IgA nephropathy (IgAN): (1) an acute reversible episode of macroscopic hematuria or (2) asymptomatic urinary abnormalities. Patients in these groups differ by genetic markers, the severity of their histologic lesions, and the rate of progression to renal insufficiency. Macroscopic hematuria is more common in children, and its frequency decreases with increasing age. In our experience, most patients presenting in adulthood with macroscopic hematuria did not have proteinuria or microscopic hematuria prior to the episode of macroscopic hematuria, suggesting the onset of disease was indeed in adulthood. IgAN is not a benign disease. About 20% of patients reach end-stage renal failure after 20 years of clinical disease. Features generally associated with a poor prognosis include older age at onset, no history of recurrent macroscopic hematuria, hypertension, and consistent proteinuria. In some studies, men progressed more rapidly than women. Using the regression of Cox in the present study, the magnitude of proteinuria was the only clinical parameter that independently predicted progressive renal impairment.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3055956     DOI: 10.1016/s0272-6386(88)80023-4

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  12 in total

Review 1.  Progress in molecular and genetic studies of IgA nephropathy.

Authors:  J Novak; B A Julian; M Tomana; J Mesteck
Journal:  J Clin Immunol       Date:  2001-09       Impact factor: 8.317

2.  Role of the deletion of polymorphism of the angiotensin converting enzyme gene in the progression and therapeutic responsiveness of IgA nephropathy.

Authors:  H Yoshida; T Mitarai; T Kawamura; T Kitajima; Y Miyazaki; R Nagasawa; Y Kawaguchi; H Kubo; I Ichikawa; O Sakai
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808

3.  Prediction of diagnosis of immunoglobulin A nephropathy prior to renal biopsy and correlation with urinary sediment findings and prognostic grading.

Authors:  Kazutaka Nakayama; Isao Ohsawa; Atsuko Maeda-Ohtani; Maki Murakoshi; Satoshi Horikoshi; Yasuhiko Tomino
Journal:  J Clin Lab Anal       Date:  2008       Impact factor: 2.352

Review 4.  [IgA nephropathy: frequent, but rarely diagnosed].

Authors:  J Floege; H-J Gröne
Journal:  Internist (Berl)       Date:  2003-09       Impact factor: 0.743

Review 5.  Acute glomerulonephritis.

Authors:  C S Vinen; D B G Oliveira
Journal:  Postgrad Med J       Date:  2003-04       Impact factor: 2.401

Review 6.  Pyroptosis: A New Frontier in Kidney Diseases.

Authors:  Ke-Jia Zhang; Qi Wu; Shi-Min Jiang; Lei Ding; Chao-Xia Liu; Ming Xu; Ying Wang; Yao Zhou; Li Li
Journal:  Oxid Med Cell Longev       Date:  2021-04-28       Impact factor: 6.543

7.  Effect of treatment on urinary kidney injury molecule-1 in IgA nephropathy.

Authors:  Mi Seon Seo; Moo Yong Park; Soo Jeong Choi; Jin Seok Jeon; Hyunjin Noh; Jin Kuk Kim; Dong Cheol Han; Seung Duk Hwang; So Young Jin; Soon Hyo Kwon
Journal:  BMC Nephrol       Date:  2013-07-09       Impact factor: 2.388

8.  Noninvasive Urinary Monitoring of Progression in IgA Nephropathy.

Authors:  Joshua Y C Yang; Reuben D Sarwal; Fernando C Fervenza; Minnie M Sarwal; Richard A Lafayette
Journal:  Int J Mol Sci       Date:  2019-09-10       Impact factor: 5.923

9.  NLRP3 Localizes to the Tubular Epithelium in Human Kidney and Correlates With Outcome in IgA Nephropathy.

Authors:  Justin Chun; Hyunjae Chung; Xiangyu Wang; Rebecca Barry; Zohreh Mohammad Taheri; Jaye M Platnich; Sofia B Ahmed; Kiril Trpkov; Brenda Hemmelgarn; Hallgrimur Benediktsson; Matthew T James; Daniel A Muruve
Journal:  Sci Rep       Date:  2016-04-20       Impact factor: 4.379

10.  Short-term anti-proteinuric effect of tacrolimus is not related to preservation of the glomerular filtration rate in IgA nephropathy: A 5-year follow-up study.

Authors:  Mi-Yeon Yu; Yong-Chul Kim; Ho Suk Koo; Ho Jun Chin
Journal:  PLoS One       Date:  2017-11-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.